- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
- 10-K Annual report
- 10.6 Third Amendment to Sublease Agreement
- 10.42 Agreement to Modify the Corporation's Compensation Arrangement
- 10.43 Amendment No. 1 to the Agreement to Modify the Corporation's Compensation Arr.
- 10.44 Agreement to Bonus Payment and Contingent Bonus Payment
- 12.1 Statement Re: Computation of Ratio of Earnings to Fixed Charges
- 21.1 Subsidiaries of the Registrant
- 23.1 Consent of Stonefield Josephson, Inc.
- 23.2 Consent of Grant Thornton LLP
- 31.1 Certification of Chief Executive Officer
- 31.2 Certification of Chief Financial Officer
- 32 Certification of Chief Executive Officer and Chief Financial Officer
Exhibit 23.2
CONSENT OF GRANT THORNTON LLP,
INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We have issued our report dated February 28, 2005, accompanying the consolidated financial statements and schedule included in the Annual Report of Cell Therapeutics, Inc. on Form 10-K for the year ended December 31, 2004. We hereby consent to the incorporation by reference of said report appearing in the Annual Report (Form 10-K) of Cell Therapeutics, Inc for the year ended December 31, 2006 in the Registration Statements of Cell Therapeutics, Inc. on Form S-3 (File Nos. 333-36038, 333-41300, 333-67906, 333-36603, 333-38431, 333-108926, 333-112681, 333- 130004, 333- 130411, 333- 131533, 333-138170 and 333-134126) and on Form S-8 (File Nos. 333-65200, 333-58957, 333-35919, 333-97015, 333-106568, 333-106571, 333-112791 and 333-118016).
/s/ Grant Thornton LLP |
Seattle, Washington
March 15, 2007